UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Gynecologic oncology, 2010-01, Vol.116 (1), p.44-49

2010

Volltextzugriff (PDF)

Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2843-2848

2003

Volltextzugriff (PDF)

Progress in Gynecologic Cancer Research: The Gynecologic Oncology Group Experience

Seminars in oncology, 2008-10, Vol.35 (5), p.507-521

Omura, George A

2008

Volltextzugriff (PDF)

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

The New England journal of medicine, 1994-10, Vol.331 (14), p.896-903

1994

Volltextzugriff (PDF)

Re: early stage high-risk ovarian cancer

Gynecologic oncology, 2007-05, Vol.105 (2), p.555-6; author reply 556

Omura, George A

2007

Volltextzugriff (PDF)

Modified Fibonacci search

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3177-3177

Omura, George A

2003

Volltextzugriff (PDF)

Phase 1 dose-finding trials and fibonacci

Clinical cancer research, 2006-01, Vol.12 (1), p.321-321

Omura, George A

2006

Volltextzugriff (PDF)

Mastering AutoCAD 2017 and AutoCAD LT 2017

1, 2016

Volltextzugriff (PDF)

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study

Gynecologic oncology, 1992-11, Vol.47 (2), p.159-166

1992

Volltextzugriff (PDF)

Re: Mucinous ovarian cancer

Gynecologic oncology, 2005-12, Vol.99 (3), p.789-789

Omura, George A.

2005

Volltextzugriff (PDF)

Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience

Cancer, 1993-01, Vol.71 (S2), p.606-614

1993

Volltextzugriff (PDF)

Natural history and treatment of mycosis fungoides

Oncology (Williston Park, N.Y.), 2004-02, Vol.18 (2), p.144; author reply 144, 149-144; author reply 144

Omura, George A

2004

Volltextzugriff (PDF)

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology, 2001-06, Vol.44 (6), p.940-947

2001

Volltextzugriff (PDF)

Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

Gynecologic oncology, 2003-08, Vol.90 (2), p.498-498

Omura, George A.

2003

Volltextzugriff (PDF)

Darier, Pautrier, and the “microabscesses” of mycosis fungoides

Journal of the American Academy of Dermatology, 2002-02, Vol.46 (2), p.320-321

Omura, George A.

2002

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Peldesine (BCX-34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers

Journal of clinical pharmacology, 2000-04, Vol.40 (4), p.410-420

2000

Volltextzugriff (PDF)

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma. Cancer and Leukemia Group B studies 8852 and 8854

Cancer, 2001-07, Vol.92 (2), p.207-217

2001

Volltextzugriff (PDF)

George A. Omura, MD, on Giving, and Not Giving, Chemotherapy

Oncology times, 2004-08, Vol.26 (15), p.7-7

Omura, George A

2004

Volltextzugriff (PDF)

Progress in Gynecologic Cancer Research : The Gynecologic Oncology Group Experience: Contributions of the Cooperative Groups

Seminars in oncology, 2008, Vol.35 (5), p.507-521

OMURA, George A

2008

Volltextzugriff (PDF)

Letter to the Editor

Gynecologic oncology, 2007-05, Vol.105 (2), p.555-556

Omura, George A.

2007

Volltextzugriff (PDF)

PII: S0090-8258(07)00038-8

Gynecologic oncology, 2007, Vol.105 (2), p.555-556

Omura, George A.

2007

Volltextzugriff (PDF)

Letter to the Editor

Gynecologic oncology, 2007, Vol.105 (2), p.555-556

Omura, George A

2007

Volltextzugriff (PDF)

Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary

Oncology (Williston Park, N.Y.), 2002-12, Vol.16 (12), p.1669-78; discussion 1678-80

2002

Volltextzugriff (PDF)

Advances in the treatment of gynecologic malignancies. Part 1: Cancers of the cervix and vulva

Oncology (Williston Park, N.Y.), 2002-11, Vol.16 (11), p.1510

2002

Volltextzugriff (PDF)

A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis

Cancer chemotherapy and pharmacology, 1996, Vol.38 (4), p.323-328

1996

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Englisch
(213)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Humans
(83)
Life Sciences & Biomedicine
(82)
Female
(54)
Oncology
(46)
General Engineering & Project Administration
(39)
General References
(39)
Middle Aged
(39)
Biological And Medical Sciences
(37)
Medical Sciences
(35)
Adult
(33)
Aged
(30)
Male
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(28)
Pharmacology. Drug Treatments
(27)
Antineoplastic Agents
(23)
Chemotherapy
(22)
Autocad
(20)
Cyclophosphamide - Administration & Dosage
(15)
Doxorubicin - Administration & Dosage
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study

Progress in Gynecologic Cancer Research: The Gynecologic Oncology Group Experience

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Re: early stage high-risk ovarian cancer

Modified Fibonacci search

Phase 1 dose-finding trials and fibonacci

Mastering AutoCAD 2017 and AutoCAD LT 2017

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study

Re: Mucinous ovarian cancer

Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience

Natural history and treatment of mycosis fungoides

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

Darier, Pautrier, and the “microabscesses” of mycosis fungoides

Pharmacokinetics and Pharmacodynamics of Peldesine (BCX-34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma. Cancer and Leukemia Group B studies 8852 and 8854

George A. Omura, MD, on Giving, and Not Giving, Chemotherapy

Progress in Gynecologic Cancer Research : The Gynecologic Oncology Group Experience: Contributions of the Cooperative Groups

Letter to the Editor

PII: S0090-8258(07)00038-8

Letter to the Editor

Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary

Advances in the treatment of gynecologic malignancies. Part 1: Cancers of the cervix and vulva

A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis

Suchergebnisse filtern